Glysantis is pleased to announce the appointment of Dr. Jondavid (Jd) de Jong, as Manager R&D. “Glysantis’ R&D portfolio has been growing rapidly and we need...

Glysantis is pleased to announce the promotion of Dr. Karl Klinger to the role of Sr. Scientist. “From his first day here, it was clear that Karl brings top-...

Glysantis Inc. is pleased to announce the appointment of Ricky Ghoshal as Director of Strategic Development. Glysantis Inc., is a biotechnology company acti...

Guelph, May 28, 2018 – Glysantis Inc., a privately held biotechnology company developing novel nanomedicines, announced today that it will be participating i...

Guelph, April 4, 2018 – Glysantis Inc. today announced that it has been selected as a finalist in the RESI at MaRS Toronto Innovation Challenge. Glysantis In...

Guelph, Jan 3, 2018 – Glysantis Inc. today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 during the most important week i...

October 5, 2017 - Guelph, ON On Thursday, September 28th Mirexus Biotechnologies Inc., parent organization of Glysantis Inc., hosted a ground-breaking ceremo...

September 1, 2017 - Guelph, ON Glysantis is pleased to announce that Ricky Ghoshal has joined Glysantis as Sr. Business Development Associate. Ricky recently...

June 21, 2016 - Guelph, ON. Mirexus Biotechnologies Inc. (MBI), a guelph-based nanomaterials company, has created a wholly-owned subsidiary called Glysantis ...